TEMOVATE E (clobetasol propionate) by Sandoz is clinical pharmacology: the corticosteroids are a class of compounds comprising steroid hormones secreted by the adrenal cortex and their synthetic analogs. First approved in 1994.
Drug data last refreshed 21h ago · AI intelligence enriched 1mo ago
TEMOVATE E (clobetasol propionate) is a super-potent topical corticosteroid cream used to treat corticosteroid-responsive dermatoses including psoriasis, eczema, and other inflammatory skin conditions. It works through anti-inflammatory, antipruritic, and vasoconstrictive mechanisms characteristic of the corticosteroid class. The drug is absorbed through intact and inflamed skin, undergoes hepatic metabolism, and can produce transient, reversible HPA axis suppression with systemic absorption.
Product is approaching loss of exclusivity with moderate competitive pressure (30/100), signaling potential team downsizing and shift toward generic support or next-generation dermatology assets.
CLINICAL PHARMACOLOGY: The corticosteroids are a class of compounds comprising steroid hormones secreted by the adrenal cortex and their synthetic analogs. In pharmacologic doses, corticosteroids are used primarily for their anti-inflammatory and/or immunosuppressive effects. Topical…
Worked on TEMOVATE E at Sandoz? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Subject Reported Target-lesion Numeric Rating Scale Evaluation by Subjects With Plaque Psoriasis Treated With Clobex® (Clobetasol Propionate) Spray 0.05%
Sandoz is hiring 1 role related to this product
Working on TEMOVATE E as a career move signals a role in a mature, stable product with limited growth runway and zero linked job openings. This is suitable for professionals seeking maintenance/defensive marketing experience or those willing to transition into generic stewardship or portfolio rationalization projects.